HENDERSON-ROSE HEALTHCARE LTDActive

Company number 13545232Private limited companyIncorporated 2021

Key figures

£7,191-58.6%
Net assets 2025/26
-7.9%
Average annual change 2021/22–2025/26
010 k20 k30 k2021/222022/232023/242024/252025/26

Like most small UK companies, HENDERSON-ROSE HEALTHCARE LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2021/222022/232023/242024/252025/26

Dividends

from the accounts
2023/24

Dividends paid in the financial year: £15,000.

Filed accounts2021/22–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand—25,56833,408——
Total assets—25,56833,40835,96724,326
Total liabilities09,48611,97418,57817,135
Net assets / total equity10,00016,08221,43417,3897,191
Average number of employees00000
Dividends paid——15,000——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HENDERSON-ROSE HEALTHCARE LTD

Company

HENDERSON-ROSE HEALTHCARE LTD is a private limited company registered with Companies House under company number 13545232. It was incorporated on 3 Aug 2021. Its status is active. The registered office is in Chelmsford (CM2). Its nature of business (SIC 2007) is medical nursing home activities (86102).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Aug 2026); the company files micro-entity accounts. Net assets were £7,191, down 58.6% on the previous year. Total assets were £24,326 and total liabilities £17,135. The company had an average of 0 employees. Figures are available for 5 financial years (2021/22–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 May 2028. The next confirmation statement is due by 16 Aug 2027.